Woodstock Corp’s Corbus Pharmaceuticals CRBP Stock Holding History

Woodstock Corp’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,907	Closed	-$103K	–	201
2020 Q3	$103K	Hold	1,907	–	–	0.02%	151
2020 Q2	$480K	Hold	1,907	–	–	0.08%	120
2020 Q1	$300K	Hold	1,907	–	–	0.06%	128
2019 Q4	$312K	Hold	1,907	–	–	0.05%	136
2019 Q3	$279K	Hold	1,907	–	–	0.05%	142
2019 Q2	$396K	Hold	1,907	–	–	0.07%	133
2019 Q1	$398K	Sell	1,907 -1,202	-39%	-$265K	0.07%	132
2018 Q4	$545K	Hold	3,109	–	–	0.11%	111
2018 Q3	$704K	Buy	3,109 +709	+30%	+$115K	0.12%	106
2018 Q2	$364K	Hold	2,400	–	–	0.07%	132
2018 Q1	$439K	Hold	2,400	–	–	0.08%	123
2017 Q4	$511K	Hold	2,400	–	–	0.09%	116
2017 Q3	$515K	Buy	2,400 +550	+30%	+$108K	0.1%	116
2017 Q2	$350K	Hold	1,850	–	–	0.07%	132
2017 Q1	$458K	Hold	1,850	–	–	0.09%	117
2016 Q4	$469K	Buy	1,850 +519	+39%	+$119K	0.1%	114
2016 Q3	$271K	Buy	+1,331	New	+$166K	0.06%	138

Other funds holding CRBP

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Woodstock Corp's CRBP Position: Q4 2020 in Review

Woodstock Corp sold out of Corbus Pharmaceuticals (CRBP) in Q4 2020, closing a stake of 1,907 shares — an estimated $103K sold.

Woodstock Corp first reported a position in CRBP in Q3 2016 and held it in 17 quarters. The position peaked at $704K in Q3 2018. 107 funds tracked by Wall St. Rank hold CRBP as of Q4 2020.

Woodstock Corp reported no remaining Corbus Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Woodstock Corp sold 1,907 Corbus Pharmaceuticals shares in Q4 2020, an estimated $103K.
Woodstock Corp first reported a position in Corbus Pharmaceuticals in Q3 2016 and held it in 17 quarters.
Woodstock Corp's Corbus Pharmaceuticals position peaked at $704K in Q3 2018.
107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2020.

Based on Woodstock Corp's 13F filing for Q4 2020, filed 6 Jan 2021.